← Evidence map

ArticleThe British journal of dermatology2024

Omalizumab used to treat bullous pemphigoid resistant to other treatments.

PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38262596